PRAME Expression in Melanocytic Tumors

By C. Lezcano, A. Jungbluth, K. Nehal, T. Hollmann, K. Busam. 2018

Subfields: Dermatology, Pathology and Forensic Medicine

Citations in the corpus

• Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland Carcinomas (2026, unknown): “However, it exhibits high expression in various cancer entities [19–21].”